US Stock MarketDetailed Quotes

Janux Therapeutics (JANX)

Watchlist
  • 14.540
  • -0.080-0.55%
Close May 7 16:00 ET
  • 14.020
  • -0.520-3.58%
Pre 05:11 ET
886.71MMarket Cap-7.90P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Janux Therapeutics (JANX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-5.55%10M
0
2,177.90%10M
0
0
30.99%10.59M
0
-82.56%439K
741.72%8.9M
-38.87%1.25M
Operating revenue
-5.55%10M
--0
2,177.90%10M
--0
--0
30.99%10.59M
--0
-82.56%439K
741.72%8.9M
-38.87%1.25M
Cost of revenue
Gross profit
Operating expense
53.21%167.67M
46.10%42.4M
24.72%45.25M
98.59%45.12M
62.97%34.9M
35.00%109.44M
56.05%29.02M
97.93%36.28M
4.19%22.72M
-4.10%21.41M
Selling and administrative expenses
1.76%41.77M
32.10%10.85M
-39.88%10.62M
33.67%10.45M
34.03%9.84M
57.03%41.05M
29.24%8.22M
174.42%17.67M
13.66%7.82M
13.60%7.34M
-General and administrative expense
1.76%41.77M
32.10%10.85M
-39.88%10.62M
33.67%10.45M
34.03%9.84M
57.03%41.05M
29.24%8.22M
174.42%17.67M
13.66%7.82M
13.60%7.34M
Research and development costs
84.09%125.9M
51.63%31.55M
86.04%34.63M
132.68%34.66M
78.07%25.06M
24.52%68.39M
69.97%20.81M
56.53%18.61M
-0.17%14.9M
-11.31%14.07M
Operating profit
-59.51%-157.67M
-46.10%-42.4M
1.65%-35.25M
-226.42%-45.12M
-73.09%-34.9M
-35.45%-98.85M
-79.85%-29.02M
-126.66%-35.84M
33.38%-13.82M
0.59%-20.16M
Net non-operating interest income expense
47.53%44.04M
18.73%10.46M
40.54%10.94M
43.20%11.26M
110.87%11.39M
103.28%29.85M
101.10%8.81M
83.35%7.78M
142.69%7.86M
91.39%5.4M
Non-operating interest income
47.53%44.04M
18.73%10.46M
40.54%10.94M
43.20%11.26M
110.87%11.39M
103.28%29.85M
101.10%8.81M
83.35%7.78M
142.69%7.86M
91.39%5.4M
Other net income (expense)
Income before tax
-64.69%-113.63M
-58.02%-31.95M
13.35%-24.31M
-468.18%-33.86M
-59.27%-23.51M
-18.36%-68.99M
-71.93%-20.22M
-142.56%-28.06M
65.96%-5.96M
15.46%-14.76M
Income tax
Net income
-64.69%-113.63M
-58.02%-31.95M
13.35%-24.31M
-468.18%-33.86M
-59.27%-23.51M
-18.36%-68.99M
-71.93%-20.22M
-142.56%-28.06M
65.96%-5.96M
15.46%-14.76M
Net income continuous Operations
-64.69%-113.63M
-58.02%-31.95M
13.35%-24.31M
-468.18%-33.86M
-59.27%-23.51M
-18.36%-68.99M
-71.93%-20.22M
-142.56%-28.06M
65.96%-5.96M
15.46%-14.76M
Minority interest income
Net income attributable to the parent company
-64.69%-113.63M
-58.02%-31.95M
13.35%-24.31M
-468.18%-33.86M
-59.27%-23.51M
-18.36%-68.99M
-71.93%-20.22M
-142.56%-28.06M
65.96%-5.96M
15.46%-14.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-64.69%-113.63M
-58.02%-31.95M
13.35%-24.31M
-468.18%-33.86M
-59.27%-23.51M
-18.36%-68.99M
-71.93%-20.22M
-142.56%-28.06M
65.96%-5.96M
15.46%-14.76M
Basic earnings per share
-42.97%-1.83
-41.67%-0.51
23.53%-0.39
-400.00%-0.55
-26.67%-0.38
3.03%-1.28
-50.00%-0.36
-104.00%-0.51
73.81%-0.11
28.57%-0.3
Diluted earnings per share
-42.97%-1.83
-41.67%-0.51
23.53%-0.39
-400.00%-0.55
-26.67%-0.38
3.03%-1.28
-50.00%-0.36
-104.00%-0.51
73.81%-0.11
28.57%-0.3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -5.55%10M02,177.90%10M0030.99%10.59M0-82.56%439K741.72%8.9M-38.87%1.25M
Operating revenue -5.55%10M--02,177.90%10M--0--030.99%10.59M--0-82.56%439K741.72%8.9M-38.87%1.25M
Cost of revenue
Gross profit
Operating expense 53.21%167.67M46.10%42.4M24.72%45.25M98.59%45.12M62.97%34.9M35.00%109.44M56.05%29.02M97.93%36.28M4.19%22.72M-4.10%21.41M
Selling and administrative expenses 1.76%41.77M32.10%10.85M-39.88%10.62M33.67%10.45M34.03%9.84M57.03%41.05M29.24%8.22M174.42%17.67M13.66%7.82M13.60%7.34M
-General and administrative expense 1.76%41.77M32.10%10.85M-39.88%10.62M33.67%10.45M34.03%9.84M57.03%41.05M29.24%8.22M174.42%17.67M13.66%7.82M13.60%7.34M
Research and development costs 84.09%125.9M51.63%31.55M86.04%34.63M132.68%34.66M78.07%25.06M24.52%68.39M69.97%20.81M56.53%18.61M-0.17%14.9M-11.31%14.07M
Operating profit -59.51%-157.67M-46.10%-42.4M1.65%-35.25M-226.42%-45.12M-73.09%-34.9M-35.45%-98.85M-79.85%-29.02M-126.66%-35.84M33.38%-13.82M0.59%-20.16M
Net non-operating interest income expense 47.53%44.04M18.73%10.46M40.54%10.94M43.20%11.26M110.87%11.39M103.28%29.85M101.10%8.81M83.35%7.78M142.69%7.86M91.39%5.4M
Non-operating interest income 47.53%44.04M18.73%10.46M40.54%10.94M43.20%11.26M110.87%11.39M103.28%29.85M101.10%8.81M83.35%7.78M142.69%7.86M91.39%5.4M
Other net income (expense)
Income before tax -64.69%-113.63M-58.02%-31.95M13.35%-24.31M-468.18%-33.86M-59.27%-23.51M-18.36%-68.99M-71.93%-20.22M-142.56%-28.06M65.96%-5.96M15.46%-14.76M
Income tax
Net income -64.69%-113.63M-58.02%-31.95M13.35%-24.31M-468.18%-33.86M-59.27%-23.51M-18.36%-68.99M-71.93%-20.22M-142.56%-28.06M65.96%-5.96M15.46%-14.76M
Net income continuous Operations -64.69%-113.63M-58.02%-31.95M13.35%-24.31M-468.18%-33.86M-59.27%-23.51M-18.36%-68.99M-71.93%-20.22M-142.56%-28.06M65.96%-5.96M15.46%-14.76M
Minority interest income
Net income attributable to the parent company -64.69%-113.63M-58.02%-31.95M13.35%-24.31M-468.18%-33.86M-59.27%-23.51M-18.36%-68.99M-71.93%-20.22M-142.56%-28.06M65.96%-5.96M15.46%-14.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -64.69%-113.63M-58.02%-31.95M13.35%-24.31M-468.18%-33.86M-59.27%-23.51M-18.36%-68.99M-71.93%-20.22M-142.56%-28.06M65.96%-5.96M15.46%-14.76M
Basic earnings per share -42.97%-1.83-41.67%-0.5123.53%-0.39-400.00%-0.55-26.67%-0.383.03%-1.28-50.00%-0.36-104.00%-0.5173.81%-0.1128.57%-0.3
Diluted earnings per share -42.97%-1.83-41.67%-0.5123.53%-0.39-400.00%-0.55-26.67%-0.383.03%-1.28-50.00%-0.36-104.00%-0.5173.81%-0.1128.57%-0.3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +18.33%
Sample Name
Sample Code
 +10.61%
Sample Name
Sample Code
 +9.89%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+8.59%
5
United States Oil Fund LP
USO
+6.31%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +21.47%
Sample Name
Sample Code
 +16.08%
Sample Name
Sample Code
 +10.54%
4
KE Holdings
BEKE
+7.47%
5
Alibaba
BABA
+6.92%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -